Quick Heal Q4 FY26: Enterprise growth, consumer slump, and a costly transition

Quick Heal Technologies ended Q4 FY26 with its sharpest profitability setback in years. Consolidated net revenue for the quarter fell to INR 48.7 crore, down 25.2% year on year. EBITDA slipped deep into the red at negative INR 29.3 crore, and PAT came in at negative INR 19.9 crore. For the full year, net revenue was INR 261.0 crore, down 6.6% year on year, with EBITDA at negative INR 29.4 crore and PAT at negative INR 10.9 crore.

Management did not try to frame the quarter as a one-off. The Managing Director described the results as the worst quarter in the company’s profitability history and positioned the pain as part of a deliberate transformation: moving from a B2C antivirus-led business to a broader cybersecurity company spanning consumer, enterprise and government. The presentation and concall both show that this shift is already visible in the revenue mix, but the cost of transition and the consumer slowdown are currently dominating reported profitability.

The revenue mix is changing, but the consumer fall is steep

One of the clearest datapoints in the deck is the long-term shift in business mix. Enterprise contribution moved from 20% of the business in FY21 to 51% in FY26. This is not presented as a passive outcome. Management said the enterprise share has grown by design, and the stated ambition is to take enterprise to around 80% to 90% of topline over the next two to three years.

However, FY26 was defined by a strong divergence between the two verticals. Using the company’s metric of gross revenues excluding deferred revenue and before adjusting for sales incentives, FY26 enterprise revenue rose 22.5% year on year to INR 148.4 crore. Over the same period, consumer revenue fell 24.7% year on year to INR 139.8 crore. The quarter-level split was even more extreme: Q4 FY26 enterprise gross revenue was INR 41.3 crore, up 28.2% year on year, while consumer gross revenue dropped to INR 11.0 crore, down 71.9% year on year.

The consumer decline was attributed to broad industry headwinds in B2C antivirus and a disruption in channel behaviour. Management cited significant IT hardware price inflation in 2026 versus 2025 and said that channel partners temporarily shifted investment focus to the hardware business. In parallel, Quick Heal tightened credit cycles to address elevated overdues, which also impacted consumer topline.

Note: Enterprise and consumer revenues above are based on gross revenues excluding deferred revenue, before adjusting for sales incentives, as stated in the company presentation.

Order book and deferred revenue improved, led by government momentum

The enterprise narrative in FY26 is anchored on government momentum and a stronger contracted pipeline. The company highlighted a five-year integrated cybersecurity solutions contract worth INR 64.25 crore. It also reported an order book of more than INR 55 crore. These are meaningful changes relative to FY25, when management said the order book stood at INR 6 crore.

Deferred revenue was another positive indicator discussed in both the deck and the concall. The presentation listed deferred revenue at INR 33.8 crore, up from INR 14.3 crore in FY25. Management linked enterprise growth to a healthy build-up in deferred revenue and order book.

On product strategy, the company positioned Seqrite as the enterprise arm and highlighted investments and launches across endpoint security, detection and response, data privacy, zero trust, and services. The concall specifically called out growth engines such as EDR, XDR and the data privacy product, along with newer service lines like Digital Risk Protection Services and Ransomware Recovery as a Service.

The company also presented an improving cloud mix within enterprise deployments. Enterprise cloud contribution increased from 23% in FY24 to 31% in FY25 and 38% in FY26, with on-prem correspondingly reducing to 62% in FY26. Management linked cloud adoption to higher relevance for solutions such as data privacy and zero trust access.

Overdues are still high, but collections improved by year-end

Working capital quality remains a key swing factor, particularly in the consumer channel. The presentation showed total overdues at INR 131.7 crore in FY24, INR 166.7 crore in FY25, a peak of INR 175.9 crore at H1 FY26, and an improvement to INR 137.6 crore by FY26 end.

Management said it tightened controls on credit cycles with partners during FY26, which impacted the consumer topline, but the clear priority was to bring down overdues. The CFO also stressed that the company has long-standing channel relationships and has navigated similar cycles earlier.

From a cash flow perspective, FY26 operating cash flow turned positive at INR 15.4 crore compared to negative INR 22.3 crore in FY25. Cash and cash equivalents still declined to INR 13.1 crore at year-end from INR 20.8 crore, driven by investing outflows. The cash flow statement noted that investing outflows included INR 22.3 crore of mutual fund investments.

Management also stated the company is debt-free and highlighted cash and investments of INR 224 crore at the end of FY26, and INR 249 crore as of the concall date.

Strategy: data privacy, services, and selective international expansion

Regulation is being positioned as a near-term tailwind. Management repeatedly referenced the DPDP Act and said it invested early to build in-house data privacy products. It also stated that several large BFSI customers have been onboarded and that interest is rising as the compliance timeline approaches May 2027.

Another strategic thread was the rise of AI-led threats and the need for predictive and proactive security. Management said AI is already being integrated across threat detection, malware classification, and response automation. It also suggested AI is being used beyond products, including internal functions, to improve speed and cost efficiency.

Internationally, the CFO stated the company has started making strategic investments in South East Asia, Middle East Africa and Latin America after initial successes, while continuing to deepen government and private enterprise penetration in India.

What to watch from here

Management said the current phase is transitional and indicated that the impact could persist for up to two more quarters. It also acknowledged that the cost structure is largely fixed, with a high manpower component, which increases earnings volatility when revenue fluctuates.

The FY26 update therefore reads as a company in the middle of a deliberate repositioning. Enterprise growth, higher deferred revenue, and a stronger order book offer some validation of the strategy. But the consumer decline and the sharp EBITDA compression show that the transition is not yet self-funding.

If Quick Heal can sustain enterprise momentum, convert the order book into recognised revenue, and keep tightening collections without further damaging the consumer channel, the mix shift could begin to stabilise reported profitability. Until then, the results reflect a business paying upfront for a multi-year strategic reset.